Innovations in State Based Licensure
This report identifies and highlights instances of temporary, limited or special practice licensure and provides guidance for medical boards toward best regulatory practices, encouraging
Showing 31-40 of 171 results
This report identifies and highlights instances of temporary, limited or special practice licensure and provides guidance for medical boards toward best regulatory practices, encouraging
This ... This report addresses the development of a minimum physician demographic and practice data set, as ... repository to provide a more accurate estimation of the current physician workforce.
The model guidelines provide a resource for medical boards in regulating licensees participating ... The model guidelines provide a resource for medical boards in regulating licensees participating in
This report addresses accreditation standards applied to ... medical school programs located outside of the U.S. and Canada, and the feasibility of establishing criteria
In 2015, the Tri-Regulator Collaborative – the Federation of State Medical Boards, National Association ... Association of Boards of Pharmacy, and the National Council of State Boards of Nursing – continued its historic
This report outlines emerging model practices for state medical and osteopathic boards for achieving greater cooperation and collaboration with other health professional boards in fulfilling
The FSMB provides ... The FSMB provides the SPEX Information Bulletin and a free, paper and pencil practice test that should ... should provide familiarity with the formats used in the exam.
Euless, Texas (January 21, 2014) – The Federation of State Medical Boards (FSMB) and FSMB Foundation ... resources to educate health care professionals on the safe and responsible prescribing of extended-release
A ... Joint Program of the FEDERATION OF STATE MEDICAL BOARDS OF THE UNITED STATES, INC., and the NATIONAL BOARD
The model policy encourages state medical boards promote the public health by making appropriate treatment ... patients, and to educate the regulatory and physician communities about the potential of new treatment